The Minoxidil Market, estimated at USD 1,203.7 Mn in 2025, is expected to exhibit a CAGR of 4.8% and reach USD 1,671.3 Mn by 2032.
The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital technologies are improving treatment outcomes and operational efficiency. Supportive regulations, rising R&D investments, and a strong focus on patient-centric care are creating new opportunities for pharmaceutical companies.
Key market players are focusing on adopting growth strategies, such as the launch of new products, which will drive the global minoxidil market growth. For instance, in September 2021, Dr. Reddy’s Laboratories Ltd., a pharmaceutical company, announced the launch of a minoxidil topical solution for the treatment of female pattern hair loss in India. The company has launched a prescription drug, minoxidil topical solution, at 2 percent and 5 percent for the treatment of female pattern hair loss. The company sells its products under the brand names, Mintop 2 percent and Mintop Eva 5 percent, respectively.
Global Minoxidil Market - Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2019, as "coronavirus disease 2019" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries, such as India, China, Brazil, and others, faced problems with regard to the transportation from one place to another.
The key players operating in the global minoxidil market are faced major challenges on various fronts due to the COVID-19 pandemic. The major challenges include the supply of raw materials for manufacturing drug formulations due to irregularities in transportation facilities. Moreover, product distributors are experiencing irregular demand for products from retailers due to the increasing patient population suffering from COVID-19 and other life-threatening disorders.
The COVID-19 pandemic caused major disruptions in clinical trial executions in the U.S., impacting key stakeholders across the market Investigative site capabilities experienced upheaval, driven by staff furloughs, social-distancing protocols, financial losses, and concerns over patient safety. Sponsors, CROs, and other organizations that support drug development shifted to remote-working environments.
Global Minoxidil Market: Key Developments
On January 19, 2023, Sun Pharmaceutical Industries Ltd., a pharmaceutical company, announced the acquisition of Concert Pharmaceuticals, Inc., a pharmaceutical company, to expand its dermatology product portfolio.
On July 25, 2023, Jupiter Wellness, Inc., a diversified company that supports health and wellness, announced the launch of Cosmofix MinoxiBoost in India. MinoxiBoost is a patented breakthrough hair booster system that improves response to minoxidil for increased hair growth. MinoxiBoost helps support healthy hair growth by enriching the hair and its sulfotransferase enzymes to give hair the boost it needs.